.Pharmacolibrary.Drugs.N_NervousSystem.N06A_Antidepressants.N06AX08_Bifemelane.Bifemelane .Pharmacolibrary.Drugs.N_NervousSystem.N06A_Antidepressants.N06AX08_Bifemelane.Bifemelane| name: | Bifemelane | |
| ATC code: | N06AX08 | route: | oral |
| compartments: | 1 | |
| dosage: | 75 | mg |
| volume of distribution: | 2.7 | L |
| clearance: | 8.5 | L/h |
| other parameters in model implementation | ||
Bifemelane is a psychoactive drug developed in Japan, primarily used as an antidepressant and cerebral activator. It is mainly prescribed for the treatment of depression, dementia, and cognitive dysfunction due to cerebrovascular disorder. It acts as a monoamine oxidase inhibitor (MAOI) and also possesses neuroprotective effects. It is not widely approved outside Japan.
Pharmacokinetic parameters for healthy adult Japanese subjects after single oral administration.